US Stock MarketDetailed Quotes

HALO Halozyme Therapeutics

Watchlist
  • 45.700
  • -0.060-0.13%
Close Nov 21 16:00 ET
  • 51.250
  • +5.550+12.14%
Pre 09:12 ET
5.81BMarket Cap15.13P/E (TTM)

Halozyme Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-12.87%115.38M
-16.53%55.79M
48.83%129.43M
61.83%388.57M
24.14%102.35M
90.15%132.41M
66.17%66.84M
81.94%86.96M
-19.81%240.11M
-0.08%82.45M
Net income from continuing operations
67.42%137.01M
24.74%93.25M
93.92%76.82M
39.31%281.59M
47.98%85.39M
32.78%81.84M
229.53%74.75M
-34.09%39.62M
-49.81%202.13M
-13.58%57.7M
Operating gains losses
--0
--1.68M
---7K
-67.08%611K
91.84%94K
--0
----
----
--1.86M
--49K
Depreciation and amortization
-11.78%20.36M
-1.44%20.33M
-1.23%20.21M
70.94%84.86M
190.88%20.69M
-20.97%23.08M
64.42%20.63M
2,529.43%20.46M
1,556.36%49.64M
820.31%7.11M
Deferred tax
-96.99%292K
23.76%14.24M
-66.68%1.29M
-13.75%34.51M
-35.79%9.42M
-62.25%9.7M
186.53%11.51M
-70.03%3.87M
125.74%40.01M
213.30%14.68M
Other non cash items
118.03%2.2M
842.66%2.12M
-4.87%2.05M
-166.78%-4.63M
777.43%5.68M
-313.02%-12.17M
-203.25%-286K
645.67%2.16M
-69.01%6.93M
125.44%647K
Change In working capital
-344.22%-53.94M
-69.70%-82.26M
56.04%21.56M
55.01%-38.67M
-413.80%-26.1M
137.06%22.09M
-566.37%-48.48M
143.62%13.81M
-2,399.38%-85.95M
-123.33%-5.08M
-Change in receivables
-346.84%-71.22M
63.84%-18.62M
5.86%38.31M
96.02%-3.34M
-117.73%-16.89M
165.67%28.85M
-444.07%-51.5M
258.81%36.19M
-1,342.65%-83.94M
-136.71%-7.76M
-Change in inventory
-45.51%1.98M
13.48%-21.4M
-454.94%-40.23M
-53.79%-26.88M
149.88%1.47M
165.94%3.63M
-61.44%-24.74M
-215.12%-7.25M
-337.16%-17.48M
-232.72%-2.95M
-Change in prepaid assets
555.42%38.48M
-994.47%-43.54M
-46.01%4.8M
145.21%4.1M
-122.68%-1.2M
-67.66%-8.45M
3,323.84%4.87M
196.87%8.88M
21.56%-9.06M
205.02%5.3M
-Change in payables and accrued expense
-1,088.21%-23.18M
-94.30%1.3M
177.83%18.69M
-151.14%-12.55M
-3,007.67%-9.48M
61.85%-1.95M
-35.22%22.89M
-299.43%-24.01M
2,002.40%24.54M
-90.61%326K
Cash from discontinued investing activities
Operating cash flow
-12.87%115.38M
-16.53%55.79M
48.83%129.43M
61.83%388.57M
24.14%102.35M
90.15%132.41M
66.17%66.84M
81.94%86.96M
-19.81%240.11M
-0.08%82.45M
Investing cash flow
Cash flow from continuing investing activities
-100.70%-167.48M
-176.44%-42.04M
-37.43%-82.68M
80.10%-96.91M
-374.86%-8.29M
-8,178.77%-83.45M
112.64%54.99M
-22.02%-60.16M
-19.87%-487.01M
99.42%-1.75M
Net PPE purchase and sale
48.47%-1.52M
-259.09%-2.58M
68.84%-3.55M
-217.96%-15.29M
-10.75%-2.6M
-192.06%-2.94M
267.67%1.62M
-2,221.84%-11.38M
-230.13%-4.81M
-1,383.54%-2.34M
Net business purchase and sale
----
----
----
--0
----
----
----
----
---999.12M
--0
Net investment purchase and sale
-106.15%-165.97M
-173.93%-39.46M
-62.21%-79.14M
-116.62%-81.62M
39.33%-5.7M
---80.51M
-90.28%53.37M
0.06%-48.79M
221.26%490.92M
96.86%-9.39M
Net other investing changes
----
----
----
----
----
----
----
----
--26.01M
--9.99M
Cash from discontinued investing activities
Investing cash flow
-100.70%-167.48M
-176.44%-42.04M
-37.43%-82.68M
80.10%-96.91M
-374.86%-8.29M
-8,178.77%-83.45M
112.64%54.99M
-22.02%-60.16M
-19.87%-487.01M
99.42%-1.75M
Financing cash flow
Cash flow from continuing financing activities
352.60%18.56M
287.65%9.48M
99.70%-489K
-212.59%-407.99M
-4,048.81%-249.92M
133.07%4.1M
-99.33%2.45M
-26,480.45%-164.61M
365.38%362.37M
104.06%6.33M
Net issuance payments of debt
--0
--0
--0
-102.16%-13.48M
--0
--0
--0
---13.48M
50.20%624.55M
--0
Net common stock issuance
--0
--0
--0
-101.19%-402.38M
-25,229,900.00%-252.3M
--0
--0
---150.08M
42.87%-200M
100.00%-1K
Proceeds from stock option exercised by employees
352.60%18.56M
287.65%9.48M
53.34%-489K
-43.92%7.88M
-65.85%2.38M
55.58%4.1M
-35.99%2.45M
-267.95%-1.05M
12.08%14.05M
61.69%6.97M
Net other financing activities
----
----
----
----
----
----
----
----
-17,877.36%-76.22M
---639K
Cash from discontinued financing activities
Financing cash flow
352.60%18.56M
287.65%9.48M
99.70%-489K
-212.59%-407.99M
-4,048.81%-249.92M
133.07%4.1M
-99.33%2.45M
-26,480.45%-164.61M
365.38%362.37M
104.06%6.33M
Net cash flow
Beginning cash position
-15.06%187.86M
69.92%164.63M
-49.56%118.37M
96.86%234.7M
85.72%274.23M
141.89%221.17M
-18.13%96.88M
96.86%234.7M
-19.56%119.22M
-70.00%147.66M
Current changes in cash
-163.22%-33.55M
-81.30%23.24M
133.57%46.26M
-200.74%-116.33M
-279.07%-155.86M
-5.63%53.06M
561.96%124.28M
-15,489.59%-137.81M
498.41%115.48M
123.34%87.04M
End cash Position
-43.73%154.32M
-15.06%187.86M
69.92%164.63M
-49.56%118.37M
-49.56%118.37M
85.72%274.23M
141.89%221.17M
-18.13%96.88M
96.86%234.7M
96.86%234.7M
Free cash flow
-12.06%113.86M
-22.28%53.21M
66.54%125.88M
58.64%373.28M
24.53%99.76M
88.65%129.47M
74.40%68.47M
59.78%75.59M
-21.04%235.3M
-2.73%80.11M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -12.87%115.38M-16.53%55.79M48.83%129.43M61.83%388.57M24.14%102.35M90.15%132.41M66.17%66.84M81.94%86.96M-19.81%240.11M-0.08%82.45M
Net income from continuing operations 67.42%137.01M24.74%93.25M93.92%76.82M39.31%281.59M47.98%85.39M32.78%81.84M229.53%74.75M-34.09%39.62M-49.81%202.13M-13.58%57.7M
Operating gains losses --0--1.68M---7K-67.08%611K91.84%94K--0----------1.86M--49K
Depreciation and amortization -11.78%20.36M-1.44%20.33M-1.23%20.21M70.94%84.86M190.88%20.69M-20.97%23.08M64.42%20.63M2,529.43%20.46M1,556.36%49.64M820.31%7.11M
Deferred tax -96.99%292K23.76%14.24M-66.68%1.29M-13.75%34.51M-35.79%9.42M-62.25%9.7M186.53%11.51M-70.03%3.87M125.74%40.01M213.30%14.68M
Other non cash items 118.03%2.2M842.66%2.12M-4.87%2.05M-166.78%-4.63M777.43%5.68M-313.02%-12.17M-203.25%-286K645.67%2.16M-69.01%6.93M125.44%647K
Change In working capital -344.22%-53.94M-69.70%-82.26M56.04%21.56M55.01%-38.67M-413.80%-26.1M137.06%22.09M-566.37%-48.48M143.62%13.81M-2,399.38%-85.95M-123.33%-5.08M
-Change in receivables -346.84%-71.22M63.84%-18.62M5.86%38.31M96.02%-3.34M-117.73%-16.89M165.67%28.85M-444.07%-51.5M258.81%36.19M-1,342.65%-83.94M-136.71%-7.76M
-Change in inventory -45.51%1.98M13.48%-21.4M-454.94%-40.23M-53.79%-26.88M149.88%1.47M165.94%3.63M-61.44%-24.74M-215.12%-7.25M-337.16%-17.48M-232.72%-2.95M
-Change in prepaid assets 555.42%38.48M-994.47%-43.54M-46.01%4.8M145.21%4.1M-122.68%-1.2M-67.66%-8.45M3,323.84%4.87M196.87%8.88M21.56%-9.06M205.02%5.3M
-Change in payables and accrued expense -1,088.21%-23.18M-94.30%1.3M177.83%18.69M-151.14%-12.55M-3,007.67%-9.48M61.85%-1.95M-35.22%22.89M-299.43%-24.01M2,002.40%24.54M-90.61%326K
Cash from discontinued investing activities
Operating cash flow -12.87%115.38M-16.53%55.79M48.83%129.43M61.83%388.57M24.14%102.35M90.15%132.41M66.17%66.84M81.94%86.96M-19.81%240.11M-0.08%82.45M
Investing cash flow
Cash flow from continuing investing activities -100.70%-167.48M-176.44%-42.04M-37.43%-82.68M80.10%-96.91M-374.86%-8.29M-8,178.77%-83.45M112.64%54.99M-22.02%-60.16M-19.87%-487.01M99.42%-1.75M
Net PPE purchase and sale 48.47%-1.52M-259.09%-2.58M68.84%-3.55M-217.96%-15.29M-10.75%-2.6M-192.06%-2.94M267.67%1.62M-2,221.84%-11.38M-230.13%-4.81M-1,383.54%-2.34M
Net business purchase and sale --------------0-------------------999.12M--0
Net investment purchase and sale -106.15%-165.97M-173.93%-39.46M-62.21%-79.14M-116.62%-81.62M39.33%-5.7M---80.51M-90.28%53.37M0.06%-48.79M221.26%490.92M96.86%-9.39M
Net other investing changes ----------------------------------26.01M--9.99M
Cash from discontinued investing activities
Investing cash flow -100.70%-167.48M-176.44%-42.04M-37.43%-82.68M80.10%-96.91M-374.86%-8.29M-8,178.77%-83.45M112.64%54.99M-22.02%-60.16M-19.87%-487.01M99.42%-1.75M
Financing cash flow
Cash flow from continuing financing activities 352.60%18.56M287.65%9.48M99.70%-489K-212.59%-407.99M-4,048.81%-249.92M133.07%4.1M-99.33%2.45M-26,480.45%-164.61M365.38%362.37M104.06%6.33M
Net issuance payments of debt --0--0--0-102.16%-13.48M--0--0--0---13.48M50.20%624.55M--0
Net common stock issuance --0--0--0-101.19%-402.38M-25,229,900.00%-252.3M--0--0---150.08M42.87%-200M100.00%-1K
Proceeds from stock option exercised by employees 352.60%18.56M287.65%9.48M53.34%-489K-43.92%7.88M-65.85%2.38M55.58%4.1M-35.99%2.45M-267.95%-1.05M12.08%14.05M61.69%6.97M
Net other financing activities ---------------------------------17,877.36%-76.22M---639K
Cash from discontinued financing activities
Financing cash flow 352.60%18.56M287.65%9.48M99.70%-489K-212.59%-407.99M-4,048.81%-249.92M133.07%4.1M-99.33%2.45M-26,480.45%-164.61M365.38%362.37M104.06%6.33M
Net cash flow
Beginning cash position -15.06%187.86M69.92%164.63M-49.56%118.37M96.86%234.7M85.72%274.23M141.89%221.17M-18.13%96.88M96.86%234.7M-19.56%119.22M-70.00%147.66M
Current changes in cash -163.22%-33.55M-81.30%23.24M133.57%46.26M-200.74%-116.33M-279.07%-155.86M-5.63%53.06M561.96%124.28M-15,489.59%-137.81M498.41%115.48M123.34%87.04M
End cash Position -43.73%154.32M-15.06%187.86M69.92%164.63M-49.56%118.37M-49.56%118.37M85.72%274.23M141.89%221.17M-18.13%96.88M96.86%234.7M96.86%234.7M
Free cash flow -12.06%113.86M-22.28%53.21M66.54%125.88M58.64%373.28M24.53%99.76M88.65%129.47M74.40%68.47M59.78%75.59M-21.04%235.3M-2.73%80.11M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data